SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

Ultreon™ 1.0 Software

Experience the Power of Automation

Ultreon 1.0 Software has step-by-step guidance to streamline the use of OCT intravascular imaging and RFR/FFR, prioritizing ease of use for interventional cardiologists (ICs)
ULTREON™ 1.0 Software

Go Beyond the Limitations of Angiography with OCT Imaging

Ultreon™ 1.0 Software is an intravascular imaging and coronary physiology software on one platform to guide percutaneous coronary intervention (PCI). Ultreon™ 1.0 Software is developed for Optical Coherence Tomography (OCT), used with OPTIS™ Next Imaging Systems.

Streamlined and intuitive, Ultreon™ 1.0 Software gives better insights to optimize patient outcomes through automation and an improved workflow.1-4

Performing PCI based on coronary angiography alone is inadequate for determining key metrics of the vessel such as the extent of coronary artery disease, plaque distribution and composition, and dimensions.5 Ultreon™ Software for OCT allows interventional cardiologists to see inside the heart during PCI and act on the obtained insights.

OCT is an imaging modality that uses near-infrared light to provide high-definition images of the artery with high precision allowing to assess lesion characteristics and plaque morphology for coronary artery disease.

  • Ultreon™ Software helps to guide physicians through PCI step-by-step following MLD MAX workflow and provides insights on morphology, vessel sizing, stent placement and post-stent optimization for more accurate decision-making.6
  • Ultreon™ Software is powered by artificial intelligence (AI) that enables automatic quantification of calcification and vessel sizing.1

Experience the Power of Automation

With the Ultreon™ 1.0 Software Simulation

  • Explore the software's intuitive interface
  • Review the streamlined workflow
  • Interact with AI-powered auto-detection and measurement features
  • Step through image acquisition for OCT and physiology
Start Simulator
Simulation Software
Ultreon 1.0 Software Simulation
Ultreon 1.0 Software Simulation

See Simply & Act Decisively During PCI with Ultreon™ 1.0 Software

See Simply

The Ultreon™ Software with an intuitive interface offers physicians user-friendly on-screen information and step-by-step guidance following MLD MAX workflow to aid with decision-making,6 to determine a proper treatment technique pre-PCI and to ensure optimal stent expansion results post-PCI.
 

Ultreon™ 1.0 Software intuitive workflow interface - MLD

Ultreon™ 1.0 Software intuitive workflow interface - MLD

Ultreon™ 1.0 Software intuitive workflow interface - MAX

Ultreon™ 1.0 Software intuitive workflow interface - MAX


Morphology

Ultreon™ 1.0 Software uses AI to automatically detect degree and thickness of calcification.1

  • Auto-detects and highlights calcification arc and max thickness7
  • Displays calcification angle and max thickness values throughout the pullback in real-time7
  • Highlights calcification overlays on the vessel with the co-registration view7

Watch how to use Ultreon™ 1.0 Software for morphology assessment

Ultreon Software Video
Learn more about Morphology
Morphology screen displaying angle and max thickness of calcification

Morphology screen displaying angle and max thickness of calcification


Sizing

Ultreon™ 1.0 Software uses AI to automatically detect external elastic lamina (EEL) and lumen to help identify landing zones for accurate stent placement.1,8

  • Provides vessel diameter measurements7
  • Facilitates measuring lesion length and identification of optimal user-adjusted stent landing zones on a single screen7
  • Autodetects and provides measurement of lumen and detectable EEL for quick visualization7
  • Facilitates stent length selection through co-registration7

Watch how to use Ultreon™ 1.0 Software to determine stent sizing

Ultreon Software Video
Learn more about Sizing
Sizing screen displaying EEL and Lumen diameter for proximal, current and distal frames

Sizing screen displaying EEL and Lumen diameter for proximal, current and distal frames

"I do OCT in 95% of all my cases and the data-driven guided interface with ULTREON™ Software has ignited an imaging revolution, making imaging interpretation easier (through automatic EEL and calcium detection) and the supported guided-user interface."

– Dr. Jonathan Hill, London UK
orange background

Act Decisively

Deployment

Ultreon™ Software provides side-by-side viewing of live and co-registered angio to help physicians guide precise stent deployment.7

  • Helps to ensure complete lesion coverage and avoid stent edges in high-risk morphology9

Watch how to use Ultreon™ 1.0 Software for stent deployment

Ultreon Software Video
Learn more about deployment
Ultreon™ 1.0 Software interface for stent deployment

Ultreon™ 1.0 Software interface for stent deployment


Review

Ultreon™ Software helps to ensure optimal stent expansion and apposition with instantaneous display of expansion and apposition results.7

Watch how to use Ultreon™ 1.0 Software to optimize stent placement

Ultreon Software Video
Learn more about post-PCI review
Ultreon™ 1.0 Software interface for review assessment

Ultreon™ 1.0 Software interface for review assessment

Watch OCT-Guided PCI Live Cases With Ultreon™ 1.0 Software

OCT-guided PCI Live Case: Calcified Lesion

This is a live PCI of a calcified lesion where physicians showcase AI-enabled Ultreon™ Software with automatic calcium detection and EEL detection among other features.

OCT-guided PCI Live Case: Long Diffuse LAD Lesion

This is a live PCI of a long diffuse LAD lesion where physicians show how to use coronary physiology and imaging assessment using one platform: Ultreon™ Software, powered by AI.

References

* Compared to AptiVue™ Imaging Software

  1. Data on file at Abbott.
  2. Zhang J, et al. Intravascular ultrasound versus angiography-guided drug-eluting stent implantation: the ULTIMATE trial. J Am Coll Cardiol. 2018;72(24):3126-3137. doi: 10.1016/j.jacc.2018.09.013.
  3. Hong M, et al. IVUS-XPL 5 Year Outcomes, TCT 2019.
  4. Jones et al. JACC Cardiovascular Interventions, 2018, vol 11 (14). “Angiography Alone Versus Angiography Plus Optical Coherence Tomography to Guide Percutaneous Coronary Intervention – Outcomes From the Pan-London PCI Cohort”.
  5. Reyes, M. The next innovation in PCI is not a stent. The value of OCT. CathLab Digest. Oct 6, 2019. Volume 27, Issue 10.
  6. Bezerra H, et al. Analysis of changes in decision-making process during optical coherence tomography-guided percutaneous coronary interventions: Insights from the LightLab Intiative. EuroPCR 2020.
  7. Ultreon™ 1.0 Software Instructions for Use (IFU). Refer to IFU for additional information.
  8. Prati, F. et al. The CLI-OPCI II Study. JACC: Cardiovascular Imaging, 2015: Vol 8, No. 11:1297-305.
  9. Kubo T, et al. Application of optical coherence tomography in percutaneous coronary intervention. Circ J. 2012;76(9):2076-2083. doi: 10.1253/circj.cj-12-0828.

MAT-2102546 v5.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

MAT-2001111 v7.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0